Table 1.

Echocardiography data of wild-type mice treated with anti-fractalkine

Parameter	Sham + IgG (n = 8)	Sham + anti-FKN (n = 6)	MI + IgG (n = 7)	MI + anti-FKN (n = 7)
HR (beats min−1)	691 ± 21	712 ± 14	708 ± 8	675 ± 29
BW (g)	30.9 ± 1.7	27.8 ± 0.8	29.7 ± 0.7	31.3 ± 0.8
LVEF (%)	80.40 ± 2.8	79.40 ± 3.9	37.44 ± 4.3**	57.23 ± 6.9††
LVDd (mm)	2.75 ± 0.09	2.80 ± 0.12	5.03 ± 0.31**	3.74 ± 0.35††
LVDs (mm)	1.26 ± 0.09	1.10 ± 0.11	4.30 ± 0.44***	2.48 ± 0.44†
PWTd (mm)	0.99 ± 0.08	0.90 ± 0.04	0.76 ± 0.04*	0.95 ± 0.07
LVAs (mm2)	0.90 ± 0.16	0.90 ± 0.22	9.68 ± 1.97**	4.27 ± 1.18†
LVAd (mm2)	4.64 ± 0.59	4.1 ± 0.25	14.66 ± 2.44**	8.75 ± 1.51
SF (%)	54.17 ± 2.70	59.1 ± 4.18	19.04 ± 4.74***	33.66 ± 6.29

Abbreviations: BW, body weight; FKN, fractalkine; HR, heart rate; LVAd, left ventricular area at diastole; LVAs, left ventricular area at systole; LVDd, left ventricular dimension at diastole; LVDs, left ventricular dimension at systole; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PWTd, posterior wall thickness at diastole; and SF, shortening fraction.

^*P < 0.05,

^**P < 0.01 and

^***P < 0.005 versus sham MI;

^†P < 0.05 and

^††P < 0.01 versus MI + IgG.